Physician profile
Thomas A Will
NPI 1891955233
$10,233.05
in general payments reported to CMS, 2019-2025
64 companies · $1,879 in 2025
The $1,879 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,332 · 2020: $333 · 2021: $1,124 · 2022: $1,755 · 2023: $1,772 · 2024: $2,038 · 2025: $1,879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,624 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,624.40 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,360.39 | 2019-2025 | Xtandi, Myrbetriq |
| Teleflex LLC | $706.54 | 2021-2025 | Urolift, Barrigel |
| Dendreon Pharmaceuticals LLC | $681.90 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $552.50 | 2019-2025 | Erleada |
| Abbvie INC. | $494.87 | 2019-2025 | Lupron Depot, Botox |
| Bayer Healthcare Pharmaceuticals INC. | $441.13 | 2019-2025 | |
| Coloplast Corp | $401.84 | 2019-2025 | Titan |
| Merck Sharp & Dohme LLC | $364.33 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Sumitomo Pharma America, INC. | $363.47 | 2023-2025 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $348.23 | 2019-2025 | Posluma |
| Novartis Pharmaceuticals Corporation | $285.89 | 2022-2025 | |
| Boston Scientific Corporation | $270.66 | 2019-2025 | General - Kidney Stone Disease |
| Pfizer INC. | $253.61 | 2019-2025 | |
| Antares Pharma, INC. | $252.51 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $240.93 | 2019-2023 | Xiaflex, Aveed, Edex |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $224.71 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $215.68 | 2019-2025 | Itind System, Uretero-Reno Videoscope |
| Laborie Medical Technologies Corp. | $192.37 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Axonics, INC. | $187.91 | 2021-2023 | Axonics, Bulkamid |
| Tolmar, INC. | $179.36 | 2023-2025 | Eligard |
| Accord Healthcare, INC. | $179.05 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $147.21 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $128.43 | 2023-2025 | Pylarify |
| Zyla Life Sciences, INC. | $109.67 | 2019-2020 | |
| Intuitive Surgical, INC. | $98.62 | 2023 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals Lp | $97.29 | 2021-2023 | Lynparza |
| 180 Medical, INC. | $94.89 | 2019-2024 | |
| Verity Pharmaceuticals INC. | $92.49 | 2024-2025 | Trelstar, Tlando |
| Myovant Sciences INC. | $87.67 | 2021-2022 | |
| Tempus Ai, INC | $83.87 | 2024 | |
| Urogen Pharma, INC. | $75.73 | 2023-2025 | Jelmyto |
| Convatec INC. | $71.42 | 2021-2024 | |
| Procept Biorobotics Corporation | $63.44 | 2022-2023 | Aquabeam Robotic System |
| Travere Therapeutics, INC. | $53.17 | 2019-2020 | |
| Mission Pharmacal Company | $52.51 | 2021-2023 | Uribel |
| Amgen INC. | $48.21 | 2022 | |
| Alnylam Pharmaceuticals INC. | $46.34 | 2021-2024 | Oxlumo |
| Immunitybio, INC. | $45.82 | 2025 | |
| Halozyme INC | $45.38 | 2023 | |
| Ferring Pharmaceuticals INC. | $44.21 | 2025 | Adstiladrin |
| Calyxo, INC. | $43.05 | 2024 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $42.79 | 2024 | Prolaris |
| Conmed Corporation | $38.46 | 2023 | Airseal |
| C. R. Bard, INC. & Subsidiaries | $33.01 | 2023 | Bard Urinary Drainage Bag |
| Neotract INC. | $32.21 | 2019-2020 | |
| Becton, Dickinson and Company | $31.59 | 2023 | Bard Urinary Drainage Bag |
| Hollister Incorporated | $26.56 | 2023 | Vapro, Infyna Chic, Onli |
| Civco Medical Instruments | $25.11 | 2025 | |
| Rochester Medical Corporation | $25.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $24.29 | 2025 | |
| Clarus Therapeutics INC. | $24.01 | 2021 | |
| Avation Medical, INC. | $23.38 | 2025 | Vivally System |
| Bluewind Medical | $21.89 | 2024 | Revi |
| Urovant Sciences INC | $21.82 | 2022 | |
| Profound Medical Corp. | $19.97 | 2025 | Tulsa-Pro |
| Medtronic, INC. | $18.98 | 2025 | Interstim |
| Pacira Pharmaceuticals Incorporated | $18.69 | 2024 | Exparel |
| Kowa Pharmaceuticals America, INC. | $18.38 | 2023 | Seglentis |
| Cook Medical LLC | $16.48 | 2024 | Cook |
| Photocure INC | $14.64 | 2023 | Cysview |
| Allergan, INC. | $14.40 | 2019 | |
| Agiliti Surgical, INC. | $14.09 | 2024 | Sonablate Hifu, Koelis Trinity Fusion Biopsy System |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$340,124.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Will listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.